novo nordisk glp 1 drugs justifies reasoning behind failed GLP-1 Alzheimer's trials Novo Nordisk CEO explains why

The benzyl alcohol preservative has been linked to severe toxicity in this population, including a potentially fatal condition known as gasping syndrome. Newborns have immature metabolic pathways and cannot efficiently metabolize benzyl alcohol, leading to its accumulation and metabolic acidosis with respiratory failure in severe cases

As predicted, our experiments showed that conditioned medium derived from CAV-1-silenced keratinocytes promotes HUVEC tube formation (although the effect did not reach statistical significance) and that the restoration of CAV-1 activity in keratinocytes significantly reduced the HUVEC tube formation induced by the conditioned medium

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

10.1111/dom.12133 32 HernandezA